News Breaks |
|
|
| January 29, 2013 |
| 10:02 EDT |  | CAT, GSK, LEN, ERIC, ANF, HOV, SWIR, GPC, CGV, TSN, PLXT, FITB, BRE, SPF | On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Abercrombie & Fitch (ANF) upgraded to Outperform from Market Perform at BMO Capital... BRE Properties (BRE) upgraded to Neutral from Sell at Goldman... CGG Veritas (CGV) upgraded to Overweight from Neutral at JPMorgan... Caterpillar (CAT) upgraded to Outperform from Market Perform at BMO Capital... Ericsson (ERIC) upgraded to Buy from Hold at Deutsche Bank... Fifth Third Bancorp (FITB) upgraded to Outperform from Market Perform at Wells Fargo... Genuine Parts (GPC) upgraded to Buy from Hold at BB&T... Lennar (LEN) upgraded to Buy from Neutral at Compass Point... PLX Technology (PLXT) upgraded to Buy from Hold at Wunderlich... Sierra Wireless (SWIR) upgraded to Outperform from Sector Perform at RBC Capital... Standard Pacific (SPF) upgraded to Buy from Neutral at Compass Point... Tyson Foods (TSN) upgraded to Buy from Underperform at BofA/Merrill... Hovnanian (HOV) upgraded to Neutral from Sell at Compass Point... GlaxoSmithKline (GSK) upgraded to Overweight from Equal Weight at Barclays... Caterpillar (CAT) upgraded to Buy from Outperform at CLSA. |
|
|
News For ANF;BRE;CGV;ERIC;FITB;GPC;LEN;PLXT;SWIR;SPF;TSN;HOV;GSK;CAT From The Last 14 Days Check below for free stories on ANF;BRE;CGV;ERIC;FITB;GPC;LEN;PLXT;SWIR;SPF;TSN;HOV;GSK;CAT the last two weeks. |
|
|
| June 19, 2013 |
| 16:19 EDT |  | ANF | Abercrombie & Fitch re-initiated with an Outperform at Oppenheimer
 Subscribe for More Information |
|
| 11:01 EDT | | SPF | Standard Pacific initiated with a Buy at Sidoti
Target $12. |
|
| June 18, 2013 |
| 11:48 EDT |  | FITB | Fifth Third Bancorp raises quarterly dividend 9% to 12c from 11c per share
The cash dividend is payable on Thursday, July 18 to shareholders of record as of Friday, June 28. |
|
| 11:47 EDT | | TSN | Hormel Foods falls after lowering profit outlook
Subscribe for More Information |
|
| 08:37 EDT |  | GSK | Drug companies turn to microchips to test medicines, WSJ reports
Subscribe for More Information |
|
| 07:13 EDT | | GSK | Aspen in talks buy GSK's Arixtra, Fraxiparine brands
Subscribe for More Information |
|
| 07:07 EDT | | GSK | GlaxoSmithKline receives offer for thrombosis brands from Aspen
GlaxoSmithKline said it received an offer for its thrombosis brands and Notre-Dame de Bondeville site from Aspen Global. A period of exclusivity has been agreed with Aspen. The financial terms are confidential at this time, but the offer includes the transfer of the Arixtra and Fraxiparine brands to Aspen, along with the related manufacturing site and the majority of employees at NDB in France and certain dedicated commercial employees, GSK said. "The proposed transaction is aligned to GSK's strategy of focusing on products with the most growth potential and the delivery of its pipeline," the company added. |
|
| June 17, 2013 |
| 11:10 EDT |  | SWIR | Sierra Wireless is likely beneficiary General Motors vehicle connectivity, says Avondale
Subscribe for More Information |
|
| 07:23 EDT |  | ANF | Jefferies to host a conference
Subscribe for More Information |
|
| June 14, 2013 |
| 09:01 EDT | | SPF | Standard Pacific announces acquisition of homebuilding assets from Centerline
Subscribe for More Information |
| |
| June 13, 2013 |
| 11:23 EDT | | ANF | Abercrombie & Fitch management to meet with ISI Group
Subscribe for More Information |
|
| June 12, 2013 |
| 19:54 EDT | | GSK | GlaxoSmithKline investigates bribe claims in China, WSJ says
Subscribe for More Information |
|
| 12:27 EDT |  | CAT | On The Fly: Midday Wrap
Subscribe for More Information |
|
| 11:42 EDT | | CAT | Caterpillar raises dividend 15% to 60c from 52c per share
Subscribe for More Information |
|
| 11:41 EDT | | CAT | Caterpillar raises dividend 15%
|
|
| 11:18 EDT |  | GPC | High option volume stocks: KNDI GPC SE KOG CLDX
|
|
| 10:14 EDT | | LEN, GPC | On the Fly: Upgrade Summary
Subscribe for More Information |
|
| 07:16 EDT | | GSK | GlaxoSmithKline fires head of R&D in China, WSJ says
GlaxoSmithKline has fired it's head of R&D in China after finding that he had incorporated "misinterpreted" data in a paper he helped write for a journal, Nature Medicine, according to The Wall Street Journal, citing the company. Reference Link |
|
| 06:54 EDT | | GPC | Genuine Parts upgraded to Neutral from Underperform at BofA/Merrill
|
|
| 05:36 EDT | | LEN | Lennar upgraded to Outperform from Market Perform at Keefe Bruyette
Subscribe for More Information |
| |
|
|
|
|
